Clinical Trials - Medika Life

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Medika Life - October 12, 2022

Tapping AliveCor Senior Executive, Cumulus Signals Progression To A Global Healthcare Company; Dr. Bhatti To Lead Expansion of AI-Based Digital Biomarker Platform To Accelerate Patient Care and Drug Development in Neurology and Neuropsychiatry

Four Ways COVID has Changed Health Tech

John Whyte MD - December 29, 2021

Like most tech lovers, I’m excited about the upcoming CES conference. I won’t be attending in person but will be watching it very closely...

This Is Why We Should NEVER Rush A Vaccine To Market

Dr. Hesham A. Hassaballa - September 10, 2020

We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

SCOPE Summit is Expected to be a Major Platform for News in Clinical Trial Innovation

Why Healing Still Begins with Relationship

AI is Transforming Health Delivery: A Five-Year Reflection

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

LATEST

TRENDING

Health Possibilities We Can’t Afford to Block

Texas: Endometriosis Clinical Study Participants – Women’s Health

AI is Transforming Health Delivery: A Five-Year Reflection

Texas: Migraine Clinical Study Participants – Men and Women

Tech Marches On, While Humanity Drags Its Feet

Four Ways COVID has Changed Health Tech

Covid’s Elephant in the Room. We Must Address it

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

It’s Time for New Tools to Overcome Smoking

Texas: Hot Flashes Clinical Study Participants – Women’s Health

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Four Ways COVID has Changed Health Tech

This Is Why We Should NEVER Rush A Vaccine To Market

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories